CL2008000140A1 - Compuestos complejos de hidrato de carbono y hierro; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar anemias sideroprivas. - Google Patents

Compuestos complejos de hidrato de carbono y hierro; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar anemias sideroprivas.

Info

Publication number: CL2008000140A1
Authority: CL; Chile
Prior art keywords: compounds; sideroprive; anemies; treat; pharmaceutical composition
Prior art date: 2007-01-19

Application number

CL200800140A

Other languages

English (en)

Inventor

Stefan Reim

Peter Geisser

Original Assignee

Vifor Int Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-01-19

Filing date

2008-01-17

Publication date

2008-05-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38441703&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008000140(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-01-17 Application filed by Vifor Int Ag filed Critical Vifor Int Ag

2008-05-16 Publication of CL2008000140A1 publication Critical patent/CL2008000140A1/es

Links

OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title 1
229910052799 carbon Inorganic materials 0.000 title 1
239000002131 composite material Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
230000036571 hydration Effects 0.000 title 1
238000006703 hydration reaction Methods 0.000 title 1
150000002506 iron compounds Chemical class 0.000 title 1
238000000034 method Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biochemistry (AREA)
Materials Engineering (AREA)
Polymers & Plastics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Diabetes (AREA)
Genetics & Genomics (AREA)
Obesity (AREA)
Biotechnology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compounds Of Iron (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Carbon And Carbon Compounds (AREA)
Medicinal Preparation (AREA)

CL200800140A 2007-01-19 2008-01-17 Compuestos complejos de hidrato de carbono y hierro; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar anemias sideroprivas. CL2008000140A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP07100803A EP1947120A1 (de)	2007-01-19	2007-01-19	Eisen-Kohlenhydrat-Komplex-Verbindungen

Publications (1)

Publication Number	Publication Date
CL2008000140A1 true CL2008000140A1 (es)	2008-05-16

Family

ID=38441703

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200800140A CL2008000140A1 (es)	2007-01-19	2008-01-17	Compuestos complejos de hidrato de carbono y hierro; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar anemias sideroprivas.

Country Status (24)

Country	Link
US (1)	US8263564B2 (es)
EP (2)	EP1947120A1 (es)
JP (1)	JP5225289B2 (es)
KR (1)	KR101200992B1 (es)
CN (1)	CN101589064B (es)
AR (1)	AR064786A1 (es)
AU (1)	AU2008206969B2 (es)
BR (1)	BRPI0807037A2 (es)
CA (1)	CA2675117C (es)
CL (1)	CL2008000140A1 (es)
ES (1)	ES2732290T5 (es)
GT (1)	GT200900204A (es)
IL (1)	IL199726A (es)
MA (1)	MA31113B1 (es)
MX (1)	MX2009007695A (es)
MY (1)	MY148299A (es)
NZ (1)	NZ578457A (es)
PE (1)	PE20090187A1 (es)
RU (1)	RU2423122C2 (es)
SA (1)	SA08290017B1 (es)
TN (1)	TN2009000303A1 (es)
TW (1)	TWI388330B (es)
WO (1)	WO2008087135A1 (es)
ZA (1)	ZA200905738B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2496595A2 (en) *	2009-11-04	2012-09-12	Symed Labs Limited	Process for the preparation of iron (iii) carboxymaltose complex
CN101967205B (zh) *	2010-10-12	2013-04-17	滨州学院	一种β-葡聚糖铁复合物及其制备方法
CN102451185A (zh) *	2010-10-19	2012-05-16	长春纳米生技公司	金属离子纳米簇组合物
WO2012104204A1 (en)	2011-01-31	2012-08-09	Vifor (International) Ag	Iron-carbohydrate complex compounds for the intravenous therapy of malaria
WO2013056085A1 (en)	2011-10-13	2013-04-18	Vidasym, Inc.	Iron-fiber composition, preparation and uses thereof
WO2014065890A1 (en) *	2012-10-25	2014-05-01	Otc Nutrition Llc	Fast dissolving solid calcium mineral supplement compositions and process of making
CN105246473B (zh) *	2012-12-21	2018-07-13	维福（国际）股份有限公司	用于缺铁症状和缺铁性贫血的治疗和预防的Fe(III)络合化合物
US9796792B2 (en)	2013-03-08	2017-10-24	Vidasym, Inc.	Metal ion-functional fiber component complex compositions, preparation and uses thereof
WO2016194000A1 (en) *	2015-05-29	2016-12-08	Sun Pharmaceutical Industries Ltd.	Composition of iron sucrose and process for its preparation
US10258647B2 (en)	2015-09-01	2019-04-16	Particle Dynamics International, Llc	Iron-polysaccharide complexes and methods for the preparation thereof
RU2625739C1 (ru) *	2016-09-28	2017-07-18	Общество с ограниченной ответственностью Научно-производственное предприятие "Эксорб"	Фармакологическая композиция на основе соединений железа
CN119488480A (zh)	2019-02-28	2025-02-21	雷尼布斯治疗公司	新型铁组合物及其制造和使用方法
CN112156109A (zh) *	2020-09-29	2021-01-01	神奈纳米医药技术(珠海)有限公司	氢氧化铁-糖络合物的制备方法及其应用
RU2763135C1 (ru) *	2021-04-23	2021-12-27	Виктор Павлович Ремез	Фармакологическая композиция для лечения железодефицитной анемии
WO2023036917A1 (en) *	2021-09-10	2023-03-16	The European Atomic Energy Community (Euratom), Represented By The European Commission	Embedded product for the transportation, storage and/or handling of lanthanides or actinides and method of manufacturing
WO2023041957A1 (en) *	2021-09-16	2023-03-23	Virchow Biotech Private Limited	Efficient process for the synthesis of iron (iii) carbohydrate complexes
CA3280511A1 (en)	2024-07-18	2026-03-01	Malian Biologicals Gmbh	Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases and iron supplementation in neurodevelopmental or psychiatric disorder

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1617463A1 (de) *	1965-11-20	1971-04-08	Bayer Ag	Verfahren zur Herstellung von injizierbaren kolloidalen Eisenzubereitungen
DE3026868C2 (de) *	1980-07-16	1986-03-13	Laboratorien Hausmann AG, St. Gallen	Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung
CA1319612C (en)	1987-07-02	1993-06-29	Haile Mehansho	Iron-calcium mineral supplements with enhanced bioavailability
US4786518A (en)	1987-07-02	1988-11-22	The Procter & Gamble Company	Iron mineral supplements
DE3844065A1 (de)	1988-12-28	1990-07-05	Orgaplan Gmbh	Glycosidische eisen-ii- und eisen-iii-komplexzubereitungen und ihre verwendung
DK172860B1 (da) *	1998-03-25	1999-08-16	Pharmacosmos Holding As	Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
US6461651B1 (en) *	2000-09-26	2002-10-08	General Mills, Inc.	Sodium-free iron complex for food fortification
RU2198665C1 (ru) *	2001-12-27	2003-02-20	Общество с ограниченной ответственностью Фирма "А-БИО"	Способ получения железосодержащего лекарственного средства
DE10249552A1 (de) *	2002-10-23	2004-05-13	Vifor (International) Ag	Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US7964568B2 (en) *	2003-05-30	2011-06-21	Chromaceutical Advanced Technologies, Inc.	Synthesis of high molecular weight iron-saccharidic complexes
WO2005116046A1 (de) *	2004-05-24	2005-12-08	Cilag Ag	Verfahren zur herstellung von eisensaccharosekomplex
CN1985489B (zh)	2004-07-09	2012-05-09	艾利森电话股份有限公司	在多媒体通信系统中提供不同服务的方法和装置
CN1739531A (zh) *	2005-09-12	2006-03-01	南京生命能科技开发有限公司	一种治疗缺铁性贫血的蔗糖铁注射液及其制备方法
CN101215338B (zh) *	2007-01-05	2010-09-15	庄茅	异麦芽低聚糖铁及其制备方法
CN101390923A (zh) *	2007-09-21	2009-03-25	韩泳平	一种红景天多糖铁复方制剂的制备及应用

2007
- 2007-01-19 EP EP07100803A patent/EP1947120A1/de not_active Withdrawn
2008
- 2008-01-04 TW TW097100346A patent/TWI388330B/zh not_active IP Right Cessation
- 2008-01-08 AR ARP080100071A patent/AR064786A1/es not_active Application Discontinuation
- 2008-01-15 RU RU2009131464/05A patent/RU2423122C2/ru active
- 2008-01-15 BR BRPI0807037-7A patent/BRPI0807037A2/pt not_active IP Right Cessation
- 2008-01-15 EP EP08707897.8A patent/EP2111416B2/de active Active
- 2008-01-15 US US12/523,331 patent/US8263564B2/en active Active
- 2008-01-15 AU AU2008206969A patent/AU2008206969B2/en not_active Ceased
- 2008-01-15 CN CN200880002590.4A patent/CN101589064B/zh not_active Expired - Fee Related
- 2008-01-15 ES ES08707897T patent/ES2732290T5/es active Active
- 2008-01-15 JP JP2009545912A patent/JP5225289B2/ja active Active
- 2008-01-15 WO PCT/EP2008/050387 patent/WO2008087135A1/de not_active Ceased
- 2008-01-15 CA CA2675117A patent/CA2675117C/en not_active Expired - Fee Related
- 2008-01-15 MY MYPI20092927A patent/MY148299A/en unknown
- 2008-01-15 MX MX2009007695A patent/MX2009007695A/es active IP Right Grant
- 2008-01-15 KR KR1020097017320A patent/KR101200992B1/ko not_active Expired - Fee Related
- 2008-01-15 NZ NZ578457A patent/NZ578457A/en not_active IP Right Cessation
- 2008-01-16 SA SA08290017A patent/SA08290017B1/ar unknown
- 2008-01-17 PE PE2008000154A patent/PE20090187A1/es not_active Application Discontinuation
- 2008-01-17 CL CL200800140A patent/CL2008000140A1/es unknown
2009
- 2009-07-07 IL IL199726A patent/IL199726A/en not_active IP Right Cessation
- 2009-07-17 GT GT200900204A patent/GT200900204A/es unknown
- 2009-07-17 TN TNP2009000303A patent/TN2009000303A1/fr unknown
- 2009-07-27 MA MA32121A patent/MA31113B1/fr unknown
- 2009-08-18 ZA ZA200905738A patent/ZA200905738B/xx unknown

Also Published As

Publication number	Publication date
ES2732290T3 (es)	2019-11-21
HK1135417A1 (en)	2010-06-04
CN101589064A (zh)	2009-11-25
JP5225289B2 (ja)	2013-07-03
MX2009007695A (es)	2009-07-29
TW200835511A (en)	2008-09-01
ES2732290T5 (es)	2022-06-07
AU2008206969A1 (en)	2008-07-24
SA08290017B1 (ar)	2011-09-13
KR20090102861A (ko)	2009-09-30
AR064786A1 (es)	2009-04-22
AU2008206969B2 (en)	2012-12-06
GT200900204A (es)	2010-07-22
WO2008087135A1 (de)	2008-07-24
US20100035830A1 (en)	2010-02-11
ZA200905738B (en)	2010-05-26
CA2675117A1 (en)	2008-07-24
EP2111416A1 (de)	2009-10-28
CN101589064B (zh)	2014-01-29
PE20090187A1 (es)	2009-03-15
EP2111416B2 (de)	2022-03-30
RU2423122C2 (ru)	2011-07-10
IL199726A (en)	2014-05-28
TN2009000303A1 (en)	2010-12-31
MA31113B1 (fr)	2010-01-04
EP1947120A1 (de)	2008-07-23
NZ578457A (en)	2011-08-26
EP2111416B1 (de)	2019-05-15
CA2675117C (en)	2014-03-25
KR101200992B1 (ko)	2012-11-13
JP2010516828A (ja)	2010-05-20
BRPI0807037A2 (pt)	2014-04-22
TWI388330B (zh)	2013-03-11
US8263564B2 (en)	2012-09-11
RU2009131464A (ru)	2011-03-10
MY148299A (en)	2013-03-29
IL199726A0 (en)	2010-04-15

Similar Documents

Publication	Publication Date	Title
CL2008000140A1 (es)	2008-05-16	Compuestos complejos de hidrato de carbono y hierro; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar anemias sideroprivas.
CL2008002319A1 (es)	2009-01-02	Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
CL2007003226A1 (es)	2008-02-08	Compuestos derivados de piridinona; composicion farmaceutica; y uso para tratar el cancer.
CL2008000369A1 (es)	2008-04-18	Compuestos derivados de piridopirimidinonas; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dolor, depresion, enfermedades cardiovasculares, enfermedades respiratorias y enfermedades psiquiatricas.
CL2007003804A1 (es)	2008-08-22	Compuestos derivados de indazol; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar condiciones inflamatorias, tales como asma, epoc.
CL2008000703A1 (es)	2008-09-26	Compuestos derivados de pirimidinas sustituidas; procedimiento para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar transtornos hematologicos.
CL2008001323A1 (es)	2009-05-29	Compuestos derivados de triazolil aminopiridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
CL2012000258A1 (es)	2012-07-06	Proceso para la preparacion de composicion de aglomerante hidraulico asperjable que contiene como principales componentes agua, agregados, aglomerante hidraulico, acelerador de fraguado, aglomerante hidraulico asperjable; composicion; y uso
CL2008000197A1 (es)	2008-08-01	Compuestos derivados de 2,4-diamino pirimidina, inhibidores de antranilamida de cinasa aurora; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
CL2008002041A1 (es)	2009-01-09	Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad.
CL2008000794A1 (es)	2008-05-30	Compuestos derivados de biarilo y heteroarilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno de hierro.
CL2007002377A1 (es)	2008-04-04	Compuestos derivados de quinazolina; procedimiento de preparacion; composicion farmaceutica; y su uso como anticancerigeno.
CL2007003061A1 (es)	2008-08-01	Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2.
CL2009001484A1 (es)	2009-12-04	Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia.
CL2008000793A1 (es)	2008-05-30	Compuestos derivados de dihidroindazol; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno del hierro.
CL2007003470A1 (es)	2008-08-22	Compuestos derivados de urea; composicion farmaceutica que comprende a dichos compuestos; y su uso como antibacterianos.
CL2008001372A1 (es)	2008-12-05	Compuestos derivados de pirazol sustituidos con heteroarilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar trastornos hiperproliferativos y enfermedades relacionadas con angiogenesis.
CL2008000094A1 (es)	2008-05-23	Compuestos derivados de pteridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para aumentar la vasodilatacion.
BRPI0814593A2 (pt)	2015-01-20	Composto, composição farmacêutica que o contém e uso do composto.
CL2008000496A1 (es)	2008-09-22	Compuestos derivados de purina; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades infecciosas, cancer, alergias y otras afecciones inflamatorias.
CL2007002971A1 (es)	2008-05-30	Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
BRPI0906475A2 (pt)	2015-07-14	Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto
CL2008001069A1 (es)	2008-08-08	Compuestos derivados de tetrahidroindazoles y tetrahidroindoles; procedimiento de preparacion; y su uso para tratar una enfermedad o trastorno relacionado con la proliferacion celular.
CL2007003232A1 (es)	2008-06-27	Compuestos derivados de 5-hidroximetil oxazolidin-2-ona; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar y prevenir infecciones bacterianas.
CL2008003712A1 (es)	2009-11-27	Compuestos derivados de tiadiazololoxifenilamidina o tiazoliloxifenilamidina; su procedimiento de preparacion; uso y procedimiento para combatir microorganismos no deseados; agente que comprende a dichos compuestos; compuestos intermediarios; y su procedimiento de preparacion.